Informal consultation on the role of therapeutics in COVID-19 prophylaxis and post-exposure prophylaxis - 1 May 2020

Overview

Agenda items

  • Meeting agenda and Goal (Chair) 
  • Proposed way forward for generating evidence and scope of the core Data Monitoring committee (WHO, Tom Fleming) 
  • MRI data and statistical platform (BMGF) 
  • Current landscape and progress update for PrEP studies (BMGF, Principal Investigators) 
  • Current landscape and progress update for PEP studies (BMGF, Principal Investigators) 
  • Progress update for Core PrEP and PEP protocols (WHO, Ira Longini) 
  • AOB and action points

All consultations on the role of therapeutics in COVID-19 prophylaxis and post-exposure prophylaxis

WHO Team
R&D Blue Print (RDB)
Number of pages
9